1. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019) Authors: Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021) Authors: Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy. (December 2019) Authors: Shen, Chia-I; Huang, Hsu-Ching; Chiang, Chi-Lu; Luo, Yung-Hung; Shiao, Tsu-Hui; Chiu, Chao-Hua Journal: Lung cancer Issue: Volume 138(2019) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials. Issue 2 (February 2020) Authors: Drilon, Alexander; Siena, Salvatore; Dziadziuszko, Rafal; Barlesi, Fabrice; Krebs, Matthew G; Shaw, Alice T; de Braud, Filippo; Rolfo, Christian; Ahn, Myung-Ju; Wolf, Jürgen; Seto, Takashi; Cho, Byoung Chul; Patel, Manish R; Chiu, Chao-Hua; John, Thomas; Goto, Koichi; Karapetis, Christos S; Arken... Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epidermal growth factor receptor mutations in non–small cell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction–based assays. Issue 4 (April 2020) Authors: Shen, Chia-I; Ho, Hsiang-Ling; Yeh, Yi-Chen; Chiu, Chao-Hua; Chou, Teh-Ying Journal: Journal of the Chinese Medical Association Issue: Volume 83:Issue 4(2020) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations. Issue 5 (May 2015) Authors: Chiu, Chao-Hua; Yang, Cheng-Ta; Shih, Jin-Yuan; Huang, Ming-Shyan; Su, Wu-Chou; Lai, Ruay-Sheng; Wang, Chin-Chou; Hsiao, Shih-Hsin; Lin, Yu-Ching; Ho, Ching-Liang; Hsia, Te-Chun; Wu, Ming-Fang; Lai, Chun-Liang; Lee, Kang-Yun; Lin, Chih-Bin; Yu-Wung Yeh, Diana; Chuang, Chi-Yuan; Chang, Fu-Kang; Ts... Journal: Journal of thoracic oncology Issue: Volume 10:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations. Issue 5 (May 2015) Authors: Chiu, Chao-Hua; Yang, Cheng-Ta; Shih, Jin-Yuan; Huang, Ming-Shyan; Su, Wu-Chou; Lai, Ruay-Sheng; Wang, Chin-Chou; Hsiao, Shih-Hsin; Lin, Yu-Ching; Ho, Ching-Liang; Hsia, Te-Chun; Wu, Ming-Fang; Lai, Chun-Liang; Lee, Kang-Yun; Lin, Chih-Bin; Yu-Wung Yeh, Diana; Chuang, Chi-Yuan; Chang, Fu-Kang; Ts... Journal: Journal of thoracic oncology Issue: Volume 10:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Erlotinib Salvage Therapy in Pulmonary Adenocarcinoma Patients With Disease Progression After Previous EGFR-TKI Treatment. (December 2016) Authors: Wu, Wen-Shuo; Wu, Chieh-Hung; Lai, Shinn-Liang; Chiu, Chao-Hua; Shih, Jen-Fu; Lee, Yu-Chin; Chen, Yuh-Min Journal: American journal of clinical oncology Issue: Volume 39:Number 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pneumatosis intestinalis induced by targeted therapy. Issue 1155 (24th November 2020) Authors: Chang, Chih-Jung; Shen, Chia-I; Wu, Ching-Lan; Chiu, Chao-Hua Journal: Postgraduate medical journal Issue: Volume 98:Issue 1155(2022) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma. (April 2023) Authors: Che, Ting-Fang; Chiu, Chao-Hua; Wu, Yu-Chung; Chen, Jia-Yang; Chou, Teh-Ying; Cheng, Yi-Chun; Chiang, Chi-Lu; Huang, Chien-Sheng; Tuang, I-Shuan; Ho, Yang-Hui; Hong, Jian-Hua; Huang, Yen-Jang; Ho, Hsiang-Ling; Chang, Ying-Chih Journal: Lung cancer Issue: Volume 178(2023) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗